Cargando…
Synthetic lethality of RB1 and aurora A is driven by stathmin-mediated disruption of microtubule dynamics
RB1 mutational inactivation is a cancer driver in various types of cancer including lung cancer, making it an important target for therapeutic exploitation. We performed chemical and genetic vulnerability screens in RB1-isogenic lung cancer pair and herein report that aurora kinase A (AURKA) inhibit...
Autores principales: | Lyu, Junfang, Yang, Eun Ju, Zhang, Baoyuan, Wu, Changjie, Pardeshi, Lakhansing, Shi, Changxiang, Mou, Pui Kei, Liu, Yifan, Tan, Kaeling, Shim, Joong Sup |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547687/ https://www.ncbi.nlm.nih.gov/pubmed/33037191 http://dx.doi.org/10.1038/s41467-020-18872-0 |
Ejemplares similares
-
Class I histone deacetylase inhibition is synthetic lethal with BRCA1 deficiency in breast cancer cells
por: Zhang, Baoyuan, et al.
Publicado: (2020) -
Histone Acetyltransferase (HAT) P300/CBP Inhibitors Induce Synthetic Lethality in PTEN-Deficient Colorectal Cancer Cells through Destabilizing AKT
por: Liu, Yifan, et al.
Publicado: (2020) -
Aurora kinase A, a synthetic lethal target for precision cancer medicine
por: Mou, Pui Kei, et al.
Publicado: (2021) -
Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells
por: Wu, Changjie, et al.
Publicado: (2018) -
Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1
por: Silva, Victoria C., et al.
Publicado: (2013)